Introducing Dapagliflozin Propanediol, the generic for Farxiga, Anti‑Diabetes Tablet – a potent SGLT2 inhibitor designed to lower blood glucose by increasing urinary glucose excretion. It significantly reduces hyperglycemia, supports weight loss, and improves cardiovascular outcomes. Experience enhanced glycemic control and metabolic balance with this advanced therapy for optimal, long-term diabetes management.